Cargando…
Pharmacogenetics of asparaginase in acute lymphoblastic leukemia
Asparaginase is a key component in leukemias and lymphomas treatment protocols and is suggested as a treatment for other malignancies in which an amino acid depletion strategy is indicated. Asparaginase intolerance is subject to inter-individual variability and can manifest as hypersensitivity react...
Autores principales: | Abaji, Rachid, Krajinovic, Maja |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992626/ https://www.ncbi.nlm.nih.gov/pubmed/35582721 http://dx.doi.org/10.20517/cdr.2018.24 |
Ejemplares similares
-
Thiopurine S-methyltransferase polymorphisms in acute lymphoblastic leukemia, inflammatory bowel disease and autoimmune disorders: influence on treatment response
por: Abaji, Rachid, et al.
Publicado: (2017) -
Asparaginase-associated toxicity in children with acute lymphoblastic leukemia
por: Hijiya, Nobuko, et al.
Publicado: (2016) -
L-asparaginase in the treatment of patients with acute lymphoblastic leukemia
por: Egler, Rachel A., et al.
Publicado: (2016) -
Current Use of Asparaginase in Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma
por: Maese, Luke, et al.
Publicado: (2022) -
The pharmacogenetics of imatinib
por: Dulucq, Stéphanie, et al.
Publicado: (2010)